NYSE:CHEHealthcare
Chemed (CHE): Assessing Valuation After Earnings Miss Draws Investor Focus
Chemed reported its latest quarterly results, with revenue coming in as expected while earnings lagged behind estimates. This earnings miss has drawn attention from investors and has sent shares down after the announcement.
See our latest analysis for Chemed.
Chemed’s share price has been under pressure lately, with a year-to-date decline of 16.3% and a 12-month total shareholder return of -22.3%. Recent earnings disappointment appears to have reinforced a fading momentum, and longer-term...